Inventor · disambiguated record
Donald A. Bergstrom
Also filed as: BERGSTROM DONALD · BERGSTROM DONALD A
3 granted patents·6 pending applications·16 citations·filing 2008–2023
67Inventor score
Top patents by PatentIndex Score
9 records- 0194US10947317B2NaPi2b-targeted antibody-drug conjugates and methods of use thereofMERSANA THERAPEUTICS INC·Filed 2017·Granted Mar 16, 2021·9 cites·15 claims
- 0285US11596694B2Compositions and methods for predicting response to NaPi2b-targeted therapyMERSANA THERAPEUTICS INC·Filed 2018·Granted Mar 7, 2023·4 cites·8 claims
- 0377US11407825B2NaPi2b-targeted polymer antibody-drug conjugates and methods of use thereofMERSANA THERAPEUTICS INC·Filed 2019·Granted Aug 9, 2022·3 cites·12 claims
- 0469US2023355787A1Compositions and methods for predicting response to napi2b-targeted therapyMERSANA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0561US2021301031A1Napi2b-targeted antibody-drug conjugates and methods of use thereofMERSANA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0657US2022332815A1NaPi2B-TARGETED POLYMER ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOFMERSANA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0756US2011166028A1Methods for predicting treatment response based on the expression profiles of biomarker genes in notch mediated cancersBERGSTROM DONALD·Filed 2008·Application pending·0 cites
- 0848US2013178391A1Methods for predicting treatment response based on the expression profiles of biomarker genes in notch mediated cancersRosetta Inpharmaceutics LLC·Filed 2013·Application pending·0 cites
- 0939US2018271996A1Combination therapies of her2-targeted antibody-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Donald A. Bergstrom files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →